175 related articles for article (PubMed ID: 23483844)
1. Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α.
Kamalakaran S; Chaganty BK; Gupta R; Guentzel MN; Chambers JP; Murthy AK; Arulanandam BP
Front Cell Infect Microbiol; 2013; 3():11. PubMed ID: 23483844
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection.
Murthy AK; Li W; Chaganty BK; Kamalakaran S; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
Infect Immun; 2011 Jul; 79(7):2928-35. PubMed ID: 21536799
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
4. OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection.
Manam S; Nicholson BJ; Murthy AK
Pathog Dis; 2013 Apr; 67(3):221-4. PubMed ID: 23620186
[TBL] [Abstract][Full Text] [Related]
5. The contribution of Chlamydia-specific CD8⁺ T cells to upper genital tract pathology.
Vlcek KR; Li W; Manam S; Zanotti B; Nicholson BJ; Ramsey KH; Murthy AK
Immunol Cell Biol; 2016 Feb; 94(2):208-12. PubMed ID: 26323581
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory transcription factor 3 protects mice from uterine horn pathology during Chlamydia muridarum genital infection.
Prantner D; Sikes JD; Hennings L; Savenka AV; Basnakian AG; Nagarajan UM
Infect Immun; 2011 Oct; 79(10):3922-33. PubMed ID: 21788382
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection.
Chen L; Lei L; Chang X; Li Z; Lu C; Zhang X; Wu Y; Yeh IT; Zhong G
J Immunol; 2010 Mar; 184(5):2602-10. PubMed ID: 20124098
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
Manam S; Thomas JD; Li W; Maladore A; Schripsema JH; Ramsey KH; Murthy AK
J Infect Dis; 2015 Jun; 211(12):2014-22. PubMed ID: 25552370
[TBL] [Abstract][Full Text] [Related]
9. Role of TRAIL-R in Primary and Secondary Genital and Respiratory Chlamydia muridarum Infections in Mice.
Pal S; Sheff S; Al-Kuhlani M; Ojcius DM; de la Maza LM
Microbiol Spectr; 2022 Aug; 10(4):e0161722. PubMed ID: 35876584
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
[TBL] [Abstract][Full Text] [Related]
11. The p47phox deficiency significantly attenuates the pathogenicity of Chlamydia muridarum in the mouse oviduct but not uterine tissues.
Dai J; Tang L; Chen J; Yu P; Chen Z; Zhong G
Microbes Infect; 2016 Mar; 18(3):190-8. PubMed ID: 26645958
[TBL] [Abstract][Full Text] [Related]
12. Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum.
Tang L; Zhang H; Lei L; Gong S; Zhou Z; Baseman J; Zhong G
PLoS One; 2013; 8(8):e71649. PubMed ID: 23940777
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia muridarum plasmid induces mouse oviduct pathology by promoting chlamydial survival and ascending infection and triggering host inflammation.
Hou S; Yue L; Xu R; Zhu C; Shan S; Wang H; Liu Q
Eur J Dermatol; 2018 Oct; 28(5):628-636. PubMed ID: 30442635
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice.
Carrasco SE; Hu S; Imai DM; Kumar R; Sandusky GE; Yang XF; Derbigny WA
PLoS One; 2018; 13(4):e0195165. PubMed ID: 29624589
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.
Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM
J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135
[TBL] [Abstract][Full Text] [Related]
17. [Role of tumor necrosis factor-α in
Chen X; Liu L; Zhang X; Lu C; Chen L; Quan S; Chen L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):388-393. PubMed ID: 32376576
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
Manam S; Chaganty BK; Evani SJ; Zafiratos MT; Ramasubramanian AK; Arulanandam BP; Murthy AK
PLoS One; 2013; 8(5):e64917. PubMed ID: 23741420
[TBL] [Abstract][Full Text] [Related]
19. Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection.
Jiang J; Karimi O; Ouburg S; Champion CI; Khurana A; Liu G; Freed A; Pleijster J; Rozengurt N; Land JA; Surcel HM; Tiitinen A; Paavonen J; Kronenberg M; Morré SA; Kelly KA
PLoS One; 2012; 7(11):e47487. PubMed ID: 23189125
[TBL] [Abstract][Full Text] [Related]
20. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.
Andrew DW; Cochrane M; Schripsema JH; Ramsey KH; Dando SJ; O'Meara CP; Timms P; Beagley KW
PLoS One; 2013; 8(9):e76664. PubMed ID: 24073293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
